SCHEMBL24252065

SCHEMBL24252065

CC(C)(C)Oc1cccc(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
RHEB Q15382 1/20 0.41
KCNH2 Q12809 1/20 0.40
TSHR P16473 2/20 0.39
KDM4E B2RXH2 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
TP53 P04637 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CASR P41180 1/20 0.38
PNMT P11086 2/20 0.38
NFKB1 P19838 1/20 0.38
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
IDO1 P14902 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3784828 0.88 KCNH2 (0.43) ALDH1A1KCNH2KDM4ECYP3A4TP53
SCHEMBL15473230 0.82 KDM4E (0.38) ALDH1A1RHEBTSHRKDM4ECYP1A2
SCHEMBL301808 0.82 ALDH1A1 (0.41) ALDH1A1RHEBKCNH2TSHRKDM4E
SCHEMBL2737124 0.81 LMNA (0.43) ALDH1A1KCNH2TSHRTDP1SMN1; SMN2
SCHEMBL18071645 0.81 KDM4E (0.37) ALDH1A1RHEBTSHRKDM4ECYP1A2
SCHEMBL12958135 0.81 KDM4E (0.37) ALDH1A1RHEBTSHRKDM4ECYP1A2
SCHEMBL3789902 0.80 L3MBTL1 (0.39) KCNH2TSHRKDM4ECYP1A2CYP2C19
SCHEMBL8653715 0.80 GRIA1 (0.48) ALDH1A1RHEBTSHRKDM4ECYP1A2
SCHEMBL5822903 0.79 ALDH1A1 (0.57) ALDH1A1TSHRKDM4ECYP1A2CYP3A4
SCHEMBL3790638 0.78 KCNH2 (0.45) ALDH1A1KCNH2TSHRKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 ALDH1A1 3002/4885RHEB 1019/4885KCNH2 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.